Physician
Cardiology
Dr. Barry D. Bertolet, MD
|
|
Give Review
Barry Bertolet practices Cardiology. He studied medicine at University of Mississippi School of Medicine. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Barry D. Bertolet, MD has written publications. He has 41 publications published with PubMed. The lastest paper is: 'The Psychophysiological Investigations of Myocardial Ischemia (PIMI) study: objective, methods, and variability of measures.' Barry Bertolet is registered with Medicare.
Publications
- Long-term follow-up of the platinum chromium TAXUS element (ION) stent: The PERSEUS Workhorse and Small Vessel Trial Five-Year Results.
- Pivotal Trial to Evaluate the Safety and Efficacy of the Orbital Atherectomy System in Treating De Novo, Severely Calcified Coronary Lesions (ORBIT II).
- Relationship of human paraoxonase-1 serum activity and genotype with atherosclerosis in individuals from the Deep South.
- Use of clopidogrel loading, enoxaparin, and double-bolus eptifibatide in the setting of early percutaneous coronary intervention for Acute coronary syndromes.
- Role of endogenous adenosine in atrial fibrillation after Coronary artery bypass graft.
- Biomedical and psychosocial predictors of Anginal frequency in patients following angioplasty with and without coronary stenting.
- Clinical and angiographic outcomes after treatment of de novo Coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospe...
- CME: what's in it for patients? Alignment with outcomes.
- Safety and feasibility of using serial infusions of nesiritide for Heart failure in an outpatient setting (from the FUSION I trial).
- The Psychophysiological Investigations of Myocardial Ischemia (PIMI) study: objective, methods, and variability of measures.
- Aminophylline in the treatment of atropine-resistant bradyasystole.
- Venous activated clotting time after intra-arterial heparin: effect of site of administration and timing of sampling.
- Bradycardia after Heart transplantation: reversal with theophylline.
- Selective attenuation by N-0861 (N6-endonorboran-2-yl-9-methyladenine) of cardiac A1 adenosine receptor-mediated effects in humans.
- Unstable Angina: relationship of clinical presentation, coronary artery pathology, and clinical outcome.
- Absence of adenosine-induced chest pain after total cardiac afferent denervation.
- Adenosine: diagnostic and therapeutic uses in cardiovascular medicine.
- Clinical development of a miniature digital ambulatory ECG transient Myocardial ischemia detection system.
- Should patients with myocardial ischemia be treated with Coronary revascularization?
- Adenosine blockade as Primary therapy for ischemia-induced accelerated idioventricular rhythm: rationale and potential clinical application.
- Theophylline reverses high-grade atrioventricular block resulting from cardiac transplant rejection.
- Effect of precordial electrocardiographic electrode placement on ST-segment measurement during exercise.
- Daily life cardiac ischaemia. Should it be treated?
- Theophylline for the treatment of atrioventricular block after Myocardial infarction.
- Late discovery of cor triatriatum as a result of unilateral Pulmonary venous obstruction.
- Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization....
- Neutropenia occurring during treatment with vesnarinone (OPC-8212).
- Unrecognized left ventricular dysfunction in an apparently healthy cocaine abuse population.
- Unrecognized left ventricular dysfunction in an apparently healthy alcohol abuse population.
- Prevalence of pseudoischemic ST-segment changes during ambulatory electrocardiographic monitoring.
- Treatment strategies for daily life silent Myocardial ischemia: a correlation with potential pathogenic mechanisms.
- Calcium antagonists in the post-Myocardial infarction setting.
- Relationship among mental stress-induced ischemia and ischemia during daily life and during exercise: the Psychophysiologic Investigations of Myocardial Ischemia (PIMI...
- Myocardial infarction related Atrial fibrillation: role of endogenous adenosine.
- Cardiac troponin. See ya later, CK!
- Differential antagonism of cardiac actions of adenosine by theophylline.
- Lysis of intravascular thrombus prior to Coronary stenting using the dispatch infusion catheter.
- Effects of A1 adenosine receptor agonism using N6-cyclohexyl-2'-O-methyladenosine in patients with left ventricular dysfunction.
- Precautions for use and adverse effects of vesnarinone: potential mechanisms and future therapies.
- Long-term benefit of the TAXUS Liberté stent in small vessels and long lesions. - TASIUS ATLAS program-.
Schools
Univ Of Ms Sch Of Med
Shands HospU Fla
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
- Choice Plus POS II
- American Republic
- Assurant Health
- Bakery & Confectionary Union Plan
- Blue Card PPO
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- GEHA
- Health Alliance
- HealthSmart
- Choice Care PPO
- Medicaid
- Medicare MCR
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Wells Fargo Insurance
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
University of Florida -
University of Mississippi School of Medicine
Drug Facts
| NPI NUMBER | 1295845444 | |
| NPPES Provider LastName | BERTOLET | |
| NPPES Provider FirstName | BARRY | |
| NPPES Provider ZIPCode | 38801 | |
| NPPES Provider State | MS | |
| Specialty Description | Cardiology | |
| Total Claim Count | 10395.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1295845444 |
| Last Name Of The Provider | BERTOLET |
| First Name Of The Provider | BARRY |
| View All |
Similar Doctors
|
|
Dr. David H. Irwin Jr., MD |
|
|
Dr. James E. Stone Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger A. Williams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roland P. Guest Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Estess Jr., MD |
|
|
Dr. Francisco J. Sierra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith A. Kyker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher P. Ingelmo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William S. Carroll, MD
This Doctor is OpenDoctor Recommended.
|